Open-to-Accrual Therapeutic Trials


Gastrointestinal Cancer

Protocol ID

Official Title

PI Name

Lead CRC

Disease Site

Phase

NLG2104 ClinicalTrials.gov: NCT02077881

A Phase 1/2 Study of Indoximod in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas

A. Nayak

Lisa Marshall

 Pancreatic Cancer

I/II

 

S1513 ClinicalTrials.gov: NCT02890355

Randomized Phase II Study of 2nd Line FOLFIRI Versus Modified FOLFIRI with PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) in Metastatic Pancreatic Cancer

S. Ghamande

Inquiries

Pancreatic Cancer

II

 

CALGB-80702 ClinicalTrials.gov: NCT01150045

CALGB-80702 ClinicalTrials.gov: NCT01150045

A Phase III Trial of 6 Versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer

S. Ghamande

Inquiries

Colon Cancer

III